Psoriatic Arthritis
News
Large study reaffirms rare risk of TNF inhibitor–induced psoriasis in patients with RA, IBD
Compared with conventional treatment, the risk of developing nonpustular psoriasis was twofold higher among patients receiving TNFi treatment.
News
No more ‘escape hatch’: Post Roe, new worries about meds linked to birth defects
Physicians fear that women won’t get the best treatments or will face dangerous risks.
Conference Coverage
Treat-to-target strategy with tapering proves effective in PsA and axSpA
A trial showed for the first time that disease activity–guided treat-to-target tapering strategies in both psoriatic arthritis and axial...
Conference Coverage
Bimekizumab calms psoriatic arthritis in phase 3 ‘BE’ trials
The dual interleukin-17 inhibitor was effective both in patients for whom TNF inhibitors failed and those who had never received a biologic...
Article
Psoriatic Arthritis Treatment Basics
Conference Coverage
Biologics, Women, and Pregnancy: What’s Known?
As more studies emerge each year, recommendations will become stronger for considering treatment by certain biological drugs, taking into account...
Conference Coverage
Izokibep improves multiple psoriatic arthritis symptoms in phase 2 study
Greater percentages of patients treated with one of two doses of the novel IL-17 blocker achieved an ACR50 response versus placebo.
News
Serum brodalumab levels linked with treatment outcomes in patients with psoriasis
Subquantifiable brodalumab levels were associated with a lack of response after 12 weeks in the study.
News
Abortion debate may affect Rx decisions for pregnant women
Enactment of abortion restrictions in a growing number of states could have a chilling effect on therapy regimens in pregnant women and their...
News
FDA approves topical tapinarof for plaque psoriasis
Approval was based on results of three studies in a phase 3 clinical trial program, PSOARING, 1, 2, and an open-label extension study, PSOARING 3...